QUESTCOR PHARMACEUTICALS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 82 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-12-09: Reporting owner BAILEY DON M; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-14: Reporting owner Medeiros David Jeffrey; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-14: Reporting owner Medeiros David Jeffrey; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-11: Reporting owner Medeiros David Jeffrey; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-12-09 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 183,339 owned after | $0.44 exercise price | 2011-12-13 | |
| 2011-11-14 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 14,258 owned after | $1.37 exercise price | 2011-11-15 | |
| 2011-11-14 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,572 75,170 owned after | $1.37 exercise price | 2011-11-15 | |
| 2011-11-11 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −104,806 0 owned after | $0.98 exercise price | 2011-11-15 | |
| 2011-11-11 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,230 0 owned after | $0.44 exercise price | 2011-11-15 | |
| 2011-11-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 213,339 owned after | $0.44 exercise price | 2011-11-14 | |
| 2011-11-08 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,100 22,607 owned after | $5.09 exercise price | 2011-11-10 | |
| 2011-11-08 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,241 0 owned after | $0.60 exercise price | 2011-11-10 | |
| 2011-11-08 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,754 0 owned after | $0.89 exercise price | 2011-11-10 | |
| 2011-11-08 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 50,000 owned after | $0.51 exercise price | 2011-11-10 | |
| 2011-11-08 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 0 owned after | $0.51 exercise price | 2011-11-10 | |
| 2011-11-08 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,933 104,806 owned after | $0.98 exercise price | 2011-11-10 | |
| 2011-11-08 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,261 0 owned after | $0.98 exercise price | 2011-11-10 | |
| 2011-11-08 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 0 owned after | $1.77 exercise price | 2011-11-10 | |
| 2011-10-31 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −75,000 275,000 owned after | $4.54 exercise price | 2011-11-02 | |
| 2011-10-31 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,002 18,241 owned after | $0.60 exercise price | 2011-11-01 | |
| 2011-10-31 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,246 26,754 owned after | $0.89 exercise price | 2011-11-01 | |
| 2011-10-31 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 30,707 owned after | $5.09 exercise price | 2011-11-01 | |
| 2011-10-28 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 0 owned after | $1.37 exercise price | 2011-11-01 | |
| 2011-10-28 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,877 0 owned after | $1.37 exercise price | 2011-11-01 | |
| 2011-10-28 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 0 owned after | $1.37 exercise price | 2011-11-01 | |
| 2011-10-28 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −27,409 7,884 owned after | $5.09 exercise price | 2011-11-01 | |
| 2011-10-28 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 55,707 owned after | $5.09 exercise price | 2011-11-01 | |
| 2011-10-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $1.47 exercise price | 2011-10-12 | |
| 2011-10-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $1.47 exercise price | 2011-10-12 | |
| 2011-10-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 243,339 owned after | $0.44 exercise price | 2011-10-12 | |
| 2011-09-12 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $1.74 exercise price | 2011-09-14 | |
| 2011-09-12 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $1.74 exercise price | 2011-09-14 | |
| 2011-09-12 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,500 2,500 owned after | $1.47 exercise price | 2011-09-14 | |
| 2011-09-12 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 7,500 owned after | $1.47 exercise price | 2011-09-14 | |
| 2011-09-12 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 0 owned after | $1.47 exercise price | 2011-09-14 | |
| 2011-08-25 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · eld by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 0 owned after | $1.74 exercise price | 2011-08-29 | |
| 2011-08-25 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · eld by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 5,000 owned after | $1.74 exercise price | 2011-08-29 | |
| 2011-08-23 | Engelke Kristine Officer (Corp. Controller & PAO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 12,000 owned after | $10.55 exercise price | 2011-08-24 | |
| 2011-08-15 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,032 0 owned after | $1.43 exercise price | 2011-08-17 | |
| 2011-08-15 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −33,123 40,000 owned after | $1.37 exercise price | 2011-08-17 | |
| 2011-08-15 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,792 0 owned after | $1.64 exercise price | 2011-08-16 | |
| 2011-08-12 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,208 5,792 owned after | $1.64 exercise price | 2011-08-16 | |
| 2011-08-11 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −60,968 0 owned after | $1.43 exercise price | 2011-08-12 | |
| 2011-08-11 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 14,032 owned after | $1.43 exercise price | 2011-08-12 | |
| 2011-08-10 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 0 owned after | $0.98 exercise price | 2011-08-12 | |
| 2011-08-05 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 15,000 owned after | $1.64 exercise price | 2011-08-09 | |
| 2011-08-04 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,513 25,000 owned after | $0.98 exercise price | 2011-08-08 | |
| 2011-05-20 | SILVERMAN LOU Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,333 16,667 owned after | $4.08 exercise price | 2011-05-23 | |
| 2011-05-20 | SILVERMAN LOU Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,667 13,333 owned after | $4.75 exercise price | 2011-05-23 | |
| 2011-05-16 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4/A | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −79,087 50,513 owned after | $0.98 exercise price | 2011-05-31 | |
| 2011-05-16 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −79,087 0 owned after | $0.98 exercise price | 2011-05-17 | |
| 2011-05-13 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4/A | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −506 129,600 owned after | $0.98 exercise price | 2011-05-31 | |
| 2011-05-13 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −506 0 owned after | $0.98 exercise price | 2011-05-17 | |
| 2011-05-13 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 0 owned after | $0.46 exercise price | 2011-05-17 | |
| 2011-05-13 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,894 0 owned after | $0.98 exercise price | 2011-05-17 | |
| 2011-04-29 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4/A | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,841 22,243 owned after | $0.60 exercise price | 2011-05-25 | |
| 2011-04-29 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 0 owned after | $1.10 exercise price | 2011-05-03 | |
| 2011-04-29 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $1.78 exercise price | 2011-05-03 | |
| 2011-04-29 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $0.84 exercise price | 2011-05-03 | |
| 2011-04-29 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $1.19 exercise price | 2011-05-03 | |
| 2011-04-29 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $0.53 exercise price | 2011-05-03 | |
| 2011-04-29 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −32,500 0 owned after | $1.04 exercise price | 2011-05-03 | |
| 2011-04-29 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $1.47 exercise price | 2011-05-03 | |
| 2011-04-29 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,841 0 owned after | $0.60 exercise price | 2011-05-03 | |
| 2011-04-29 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −200,000 0 owned after | $1.02 exercise price | 2011-05-03 | |
| 2011-02-16 | Mulroy Michael H. Officer (Sr VP, CFO & General Counsel) | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $14.24 exercise price | 2011-02-18 | |
| 2011-02-16 | Young David Officer (Chief Scientific Officer) | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $14.24 exercise price | 2011-02-18 | |
| 2011-02-16 | BAILEY DON M Director, Officer (President & CEO) | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $14.24 exercise price | 2011-02-18 | |
| 2011-02-16 | BAILEY DON M Director, Officer (President & CEO) | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $14.24 exercise price | 2011-02-18 | |
| 2011-02-16 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $14.24 exercise price | 2011-02-18 | |
| 2011-02-16 | Cartt Stephen LaHue Officer (Executive VP & CBO) | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $14.24 exercise price | 2011-02-18 | |
| 2011-02-16 | Medeiros David Jeffrey Officer (Senior VP, Pharm. Operations) | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $14.24 exercise price | 2011-02-18 | |
| 2011-01-18 | Engelke Kristine Officer (Corp. Controller & PAO) | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,600 1,600 owned after | $15.42 exercise price | 2011-02-11 | |
| 2011-01-01 | BLUTT MITCHELL J MD Director | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | BLUTT MITCHELL J MD Director | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | SILVERMAN LOU Director | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | SILVERMAN LOU Director | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | SILVERMAN LOU Director | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | THOMPSON VIRGIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | BRADSHER NEAL C Director | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 250,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | BRADSHER NEAL C Director | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 260,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | BRADSHER NEAL C Director | 4 | STOCK OPTION (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 275,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | FARRELL STEPHEN C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | FARRELL STEPHEN C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $14.73 exercise price | 2011-01-04 | |
| 2011-01-01 | FARRELL STEPHEN C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $14.73 exercise price | 2011-01-04 |